Chlorpheniramine and pseudoephedrine and Lasmiditan
Determining the interaction of Chlorpheniramine and pseudoephedrine and Lasmiditan and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.MONITOR: Coadministration with alcohol or other central nervous system (CNS) depressants may enhance the sedative effects of lasmiditan and increase the likelihood and/or severity of cognitive and/or neuropsychiatric adverse reactions. Patients treated with lasmiditan are at risk of CNS depression, including dizziness and sedation, as well as driving impairment. In clinical studies, dizziness and sedation were reported in up to 17% and 7%, respectively, of patients receiving lasmiditan, and dizziness was the most common adverse event resulting in discontinuation (greater than 2%). In a computer-based driving study, a significant, dose-dependent impairment of subjects' ability to drive was observed with single 50, 100, and 200 mg lasmiditan doses at 90 minutes after administration. Concomitant use of lasmiditan and CNS depressants has not been studied clinically. MANAGEMENT: Caution is advised during coadministration of lasmiditan with alcohol, other CNS depressants, or other agents that cause sedation. Patients should be advised against driving and other activities that require complete mental alertness for at least 8 hours after lasmiditan is administered. References "Product Information. Reyvow (lasmiditan)." Lilly, Eli and Company, Indianapolis, IN.
Professional:MONITOR: Coadministration with alcohol or other central nervous system (CNS) depressants may enhance the sedative effects of lasmiditan and increase the likelihood and/or severity of cognitive and/or neuropsychiatric adverse reactions. Patients treated with lasmiditan are at risk of CNS depression, including dizziness and sedation, as well as driving impairment. In clinical studies, dizziness and sedation were reported in up to 17% and 7%, respectively, of patients receiving lasmiditan, and dizziness was the most common adverse event resulting in discontinuation (greater than 2%). In a computer-based driving study, a significant, dose-dependent impairment of subjects' ability to drive was observed with single 50, 100, and 200 mg lasmiditan doses at 90 minutes after administration. Concomitant use of lasmiditan and CNS depressants has not been studied clinically.
MANAGEMENT: Caution is advised during coadministration of lasmiditan with alcohol, other CNS depressants, or other agents that cause sedation. Patients should be advised against driving and other activities that require complete mental alertness for at least 8 hours after lasmiditan is administered.
- "Product Information. Reyvow (lasmiditan)." Lilly, Eli and Company, Indianapolis, IN.
Generic Name: chlorpheniramine / pseudoephedrine
Brand name: Allerest Maximum Strength, Dicel, LoHist-D, SudoGest Sinus & Allergy, Triaminic Cold and Allergy, Clorfed, Histalet, Fedahist, Tanafed, Novafed A, Chlorafed HS. Timecelles, Codimal-LA, Kronofed-A-Jr, Rescon, Rescon JR, Dura-Tap/PD, Fedahist Timecaps, Orlenta, Chlorphedrin SR, Colfed-A, D-Amine-SR, Deconomed SR, Pseudocot-C, Duralex, Rinade-BID, Suphenamine-SR, Isophen-DF, Kronofed-A, ND Clear, Chlordrine SR, Anamine TD, Time-Hist, Chlorafed Timecelles, Brexin LA, Rescon-Ed, Deconamine SR, Pseudochlor, Cophene No. 2, Anaplex, Anamine, Klerist-D, Codimal-LA Half, Fedahist Gyrocaps, Deconamine, Clorfed II, Curaler, Sudafed Plus, Chlorafed, Histafed LA, Chlor Trimeton Allergy Decongestant, Aller-Chlor Decongestant, Sudogest Plus, Ryna Liquid, Genaphed Plus, Dayquil Allergy, Hayfebrol Liquid, Suphedrine Plus, Atrohist Pediatric Capsule, Histex, Triaminic Softchew Cold and Allergy, Chlor-Trimeton Allergy Decongestant SR, Tavist-DA, Biohist LA, Dynahist-ER Pediatric, Pediacare Cold and Allergy, CP-Tannic, Durafed, Histade, Duotan, Mintex, QDall, Suclor, Sudafed Sinus/Allergy, Re2+30, Sudal-12, Pediox Chewable, C-Phed Tannate, De-Congestine, Sudal-12 Chewable, Sudal-12 Tannate, SudaHist, Triaminic Softchews Allergy Nose & Congestion, Duratuss DA, Neutrahist Drops, AccuHist Drops, Sudogest Cold & Allergy, Dicel Chewables, PediaCare Cold/Allergy
Synonyms: Chlorphen Mal, Pseudoeph HCl
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Chlorpheniramine and pseudoephedrine-Latanoprost
- Chlorpheniramine and pseudoephedrine-Latanoprost and netarsudil ophthalmic
- Chlorpheniramine and pseudoephedrine-Latanoprost and Timolol
- Chlorpheniramine and pseudoephedrine-Latanoprost Eye Drops (Emulsion)
- Chlorpheniramine and pseudoephedrine-Latanoprost Eye Drops (Solution)
- Chlorpheniramine and pseudoephedrine-Latanoprost ophthalmic
- Lasmiditan-Chlorpheniramine and Pseudoephedrine Liquid
- Lasmiditan-Chlorpheniramine and Pseudoephedrine Tablets
- Lasmiditan-Chlorpheniramine Extended-Release Tablets
- Lasmiditan-Chlorpheniramine Liquid
- Lasmiditan-Chlorpheniramine Syrup
- Lasmiditan-Chlorpheniramine Tablets